-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Globus Medical, Raises Price Target to $114

Benzinga·11/10/2025 18:47:06
Listen to the news
Barclays analyst Matt Miksic maintains Globus Medical (NYSE:GMED) with a Overweight and raises the price target from $106 to $114.